EV/EBITDA
-10.46
-0.01-0.10%
81 min ago
Summary
- As of March 13, 2025, TRVI EV/EBITDA is -10.46, with a fall of -0.01 (-0.10%) during the most recent trading day.
- Over the past year, TRVI EV/EBITDA has dropped by -4.28 (-69.26%).
- TRVI EV/EBITDA is now -1135.64% below its all-time high of 1.01.
Performance
TRVI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TRVI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.1% | +0.2% | +0.2% |
| 1 m1 month | -46.9% | +46.9% | +44.8% |
| 3 m3 months | -71.5% | +71.6% | +67.8% |
| 6 m6 months | -77.3% | +103.0% | +88.2% |
| ytdytd | -56.8% | +56.9% | +54.1% |
| 1 y1 year | -69.3% | +162.0% | +104.3% |
| 5 y5 years | -9409.1% | +10000.0% | +85.4% |
TRVI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -58.0% | -10.71 | +2.3% | |
| 3 m | 3-month | -6.06 | -72.6% | -10.71 | +2.3% |
| 6 m | 6-month | -3.85 | -171.7% | -10.71 | +2.3% |
| 1 y | 1-year | -3.85 | -171.7% | -10.71 | +2.3% |
| 3 y | 3-year | -0.47 | -2125.5% | -10.71 | +2.3% |
| 5 y | 5-year | 1.01 | -1135.6% | -10.71 | +2.3% |
| alltime | all time | 1.01 | -1135.6% | -10.71 | +2.3% |
Trevi Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -10.46(+56.8%) |
| 2024 | -6.67(+216.1%) |
| 2023 | -2.11(-46.6%) |
| Date | Value |
|---|---|
| 2022 | -3.95(<-9900.0%) |
| 2021 | 0.00(-100.0%) |
| 2020 | -0.44(+15.8%) |
| 2019 | -0.38 |
FAQ
- What is Trevi Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Trevi Therapeutics?
- What is TRVI EV/EBITDA year-to-date change?
- What is Trevi Therapeutics EV/EBITDA year-on-year change?
What is Trevi Therapeutics EV/EBITDA?
The current EV/EBITDA of TRVI is -10.46
What is the all time high EV/EBITDA for Trevi Therapeutics?
Trevi Therapeutics all-time high EV/EBITDA is 1.01
What is TRVI EV/EBITDA year-to-date change?
Trevi Therapeutics EV/EBITDA has changed by -3.79 (-56.82%) since the beginning of the year
What is Trevi Therapeutics EV/EBITDA year-on-year change?
Over the past year, TRVI EV/EBITDA has changed by -4.28 (-69.26%)